Evidence map›Paper›PMID 31687404›Full record

ReviewBioMed research international2019

Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages.

Jingtong Zheng, He Pan, Yinuo Gu, Xu Zuo, Nan Ran, Yuze Yuan, Chao Zhang, Fang Wang

Abstract readReview
In one paragraph

Review in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Age-structured vaccination strategies in mathematical modeling of malaria transmission.Current research in parasitology & vector-borne diseases · 2025
    Article
  4. Review
  5. A landscape review of malaria vaccine candidates in the pipeline.Tropical diseases, travel medicine and vaccines · 2024
    Review
  6. Genetic variation of theFrontiers in parasitology · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in immunology · 2022
    Review
  13. ExploringFrontiers in immunology · 2022
    Article
  14. Immunosuppression in Malaria: DoPathogens (Basel, Switzerland) · 2021
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingtong ZhengDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0003-4615-3734
He PanDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0002-6128-5375
Yinuo GuDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.
Xu ZuoDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0002-4901-3262
Nan RanDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0002-0166-8243
Yuze YuanDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0002-1940-7324
Chao ZhangDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0001-7460-2432
Fang WangDepartment of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130000, China.ORCID https://orcid.org/0000-0003-0871-3454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is a disease of public health importance in many parts of the world. Currently, there is no effective way to eradicate malaria, so developing safe, efficient, and cost-effective vaccines against this disease remains an important goal. Current research on malaria vaccines is focused on developing vaccines against pre-erythrocytic stage parasites and blood-stage parasites or on developing a transmission-blocking vaccine. Here, we briefly describe the progress made towards a vaccine against

Indexed as

AnimalsAntigens, ProtozoanCost-Benefit AnalysisErythrocytesHumansMalaria, FalciparumMalaria VaccinesPlasmodium falciparumAntigens, ProtozoanMalaria Vaccines

Identifiers

PMID31687404
PMCPMC6794966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.